| CAS NO: | 287194-38-1 |
| 包装 | 价格(元) |
| 2mg | 电议 |
| 5mg | 电议 |
| Cas No. | 287194-38-1 |
| 别名 | rel-DHMEQ |
| Canonical SMILES | O=C1[C@H]2[C@H](O2)[C@H](O)C(NC(C3=C(O)C=CC=C3)=O)=C1.O=C4[C@@H](O5)[C@@H]5[C@@H](O)C(NC(C6=C(O)C=CC=C6)=O)=C4.[relative stereochemistry] |
| 分子式 | C13H11NO5 |
| 分子量 | 261.23 |
| 溶解度 | DMSO : ≥ 32 mg/mL (122.50 mM) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | DHMEQ racemate is a NF-κB inhibitor. DHMEQ racemate is less active than (-)-DHMEQ. DHMEQ racemate (DHM3EQ) and (-)-DHMEQ (DHM2EQ) inhibits TNF-a-induced NF-kB activation. (-)-DHMEQ is more potent and less toxic than DHMEQ racemate[1]. The antiarthritic effects of (-)-DHMEQ (DHM2EQ) and DHMEQ racemate (DHM3EQ) are examined on type-II collagen-induced arthritis in DBA1/J mice. This animal model is widely used for evaluation of antirheumatic drugs because of its pathological similarities to human rheumatoid arthritis. The arthritis is elicited and scored. (-)-DHMEQ markedly inhibits type-II-collagen-induced arthritis in mice, whereas DHMEQ racemate tends to only slightly inhibit it[1]. [1]. Matsumoto N, et al. Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C. Bioorg Med Chem Lett. 2000 May 1;10(9):865-9. |
m.cnreagent.com